Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Other frequent effects include vomiting, constipation, abdominal pain, and headache, typically occurring during initial treatment or dose increases
Ask your healthcare provider to submit a prior authorization
Semaglutide is a prescription medication approved by the U.S
Gallbladder and pancreatic risks, while low in absolute terms, require monitoring, especially in patients with a history of gallstones or pancreatitis
You should arrange a consultation if: You have not had a lipid profile check within the past 12 months as part of your annual diabetes review You experience new or worsening symptoms that might indicate cardiovascular problems, such as chest pain, unusual breathlessness, or leg pain when walking (claudication) You have a family history of premature cardiovascular disease or familial hypercholesterolaemia, which may require more intensive cholesterol management You are experiencing side effects from Rybelsus such as persistent nausea, vomiting, or abdominal pain (particularly if severe and persistent, which could indicate pancreatitis) You notice new or worsening vision problems , which should be promptly discussed with your healthcare team You experience symptoms of hypoglycaemia (particularly if taking Rybelsus alongside sulfonylureas or insulin) You wish to discuss whether your current cholesterol management is optimal or if additional treatments might be beneficial Before starting Rybelsus , your GP should have assessed your overall cardiovascular risk profile, including cholesterol levels
US$ 23.45
US$ 20.92
US$ 27.72
US$ 28.61
US$ 27.52
US$ 24.95
US$ 27.99
